Sanchez; Ruben Alvarez
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sanchez; Ruben Alvarez.The latest application filed is for "antisense oligonucleotides for modulating htra1 expression".
- Sanchez; Ruben Alvarez - Basel CH
- Sanchez; Ruben Alvarez - Rosenau FR
| Patent | Date |
|---|---|
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20220042022 - Sanchez; Ruben Alvarez ; et al. | 2022-02-10 |
| Companion Diagnostic For Htra1 Rna Antagonists App 20200378970 - Sanchez; Ruben Alvarez ; et al. | 2020-12-03 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20200157546 - Sanchez; Ruben Alvarez ; et al. | 2020-05-21 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20190055564 - Sanchez; Ruben Alvarez ; et al. | 2019-02-21 |
| Proline derivatives Grant 8,163,793 - Sanchez , et al. April 24, 2 | 2012-04-24 |
| Cyclopentane derivatives Grant 7,893,099 - Banner , et al. February 22, 2 | 2011-02-22 |
| Novel Cyclopentane Derivatives App 20100317647 - Banner; David ; et al. | 2010-12-16 |
| Novel Proline Derivatives App 20100267722 - Sanchez; Ruben Alvarez ; et al. | 2010-10-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 